Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
VLLIX vs AINT
Shared holdings
10
VLLIX covered by AINT
47.00%
AINT covered by VLLIX
47.00%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 32 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
VLLIX (March 31, 2026)
| Security | Weight | |
|---|---|---|
| NVIDIA CORP | 7.41% | |
| META PLATFORMS INC CL A | 6.16% | |
| ALPHABET INC CL A | 5.87% | |
| ADV MICRO DEVICE | 5.63% | |
| BROADCOM INC | 4.76% | |
| NETFLIX INC | 4.71% | |
| MADRIGAL PHARMACEUTICALS INC | 4.68% | |
| APPLOVIN CORP | 4.45% | |
| AMAZON.COM INC | 4.31% | |
| COINBASE GLOBAL INC | 3.76% | |
| UBER TECHNOLOGIES INC | 3.46% | |
| EXELIXIS INC | 3.42% | |
| TESLA INC | 3.33% | |
| MICROSOFT CORP | 3.31% | |
| STRATEGY INC CL A | 3.14% | |
| ROBINHOOD MARKETS INC | 2.97% | |
| INSMED INC | 2.74% | |
| CROWDSTRIKE HOLDINGS INC | 2.62% | |
| COREWEAVE INC | 2.56% | |
| VISA INC-CLASS A | 2.54% | |
| SERVICENOW INC | 2.49% | |
| ARM HOLDINGS LTD | 2.41% | |
| SALESFORCE INC | 2.35% | |
| VERTEX PHARMACEUTICALS INC | 1.62% | |
| MICRON TECHNOLOGY INC | 1.61% | |
| SHOPIFY INC CL A | 1.43% | |
| ROKU INC CLASS A | 1.38% | |
| PALANTIR TECHNOLOGIES INC | 1.35% | |
| RIVIAN AUTOMOTIVE INC | 1.35% | |
| LILLY ELI and CO | 1.16% | |
| State Street Navigator Securities Lending Portfolio II | 0.58% | |
| State Street Navigator Securities Lending Government Money Market Portfolio | 0.46% |
AINT (March 31, 2026)
| Security | Weight | |
|---|---|---|
| META PLATFORMS INC CL A | 8.48% | |
| ORACLE CORP | 8.47% | |
| BROADCOM INC | 8.41% | |
| NVIDIA CORP | 8.38% | |
| ALPHABET INC CL A | 8.37% | |
| ADV MICRO DEVICE | 8.26% | |
| AMAZON.COM INC | 8.25% | |
| NETFLIX INC | 8.24% | |
| DATADOG INC CL A | 8.23% | |
| MICROSOFT CORP | 8.18% | |
| SALESFORCE INC | 8.06% | |
| SERVICENOW INC | 7.96% | |
| FRST AM-GV OB-X | 0.72% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.